LXEO financials

Lexeo Therapeutics (LXEO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

LXEO income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$109.26M-$99.96M-1.86
2024––-$105.77M-$98.33M-3.09
2023––-$68.51M-$66.39M-12.40
2022$654.00K–-$60.51M-$59.28M-36.36